Related Experiment Video
Updated: Dec 20, 2025

12:17
Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells
Published on: January 2, 2016
8.8K
Progress in Modeling and Targeting Inner Ear Disorders with Pluripotent Stem Cells
Pei-Ciao Tang1, Eri Hashino2, Rick F Nelson1
1Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Stem Cell Reports
|May 23, 2020
Summary
Pluripotent stem cells (PSCs) offer a promising avenue for regenerating inner ear cells lost in sensorineural hearing loss and vestibular dysfunction. Further research aims to improve cell survival and restore function for therapeutic applications.
Area of Science:
- Regenerative Medicine
- Otic Biology
- Stem Cell Therapy
Background:
- Sensorineural hearing loss and vestibular dysfunction stem from irreversible damage to inner ear neurons and hair cells.
- Current treatments for these conditions are limited due to the lack of regeneration in human auditory and vestibular systems.
Purpose of the Study:
- To explore the potential of pluripotent stem cells (PSCs) in generating inner ear hair cells and neurons.
- To investigate methods for enhancing the efficiency, reproducibility, and scalability of PSC differentiation protocols.
- To advance the understanding of inner ear development and disease modeling using PSCs.
Main Methods:
- Utilizing knowledge of inner ear development to refine protocols for directing PSC differentiation.
- Employing genetic manipulation of PSCs for in vitro modeling of inner ear diseases.
- Conducting transplantation studies of PSC-derived otic progenitors in animal models.
Main Results:
- Protocols have been developed to generate inner ear hair cells and neurons from PSCs with properties similar to native cells.
- In vitro disease modeling through PSC genetic manipulation is feasible, aiding mechanistic understanding.
- Initial transplantation studies in animal models show promise, but functional restoration and long-term cell survival require further investigation.
Conclusions:
- PSC-based approaches hold significant potential for revolutionizing the understanding of inner ear biology.
- Continued research is crucial for developing effective therapeutic strategies for inner ear disorders using PSCs.
- Addressing challenges in cell survival and functional restoration post-transplantation is key for clinical translation.
Related Concept Videos
EPS and iPS Cells in Disease Research
3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Induced Pluripotent Stem Cells
27.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
27.1K
Induced Pluripotent Stem Cells
5.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.2K

